# FDA Inspection 878699 - Recipharm Karlskoga AB - May 15, 2014

Source: https://www.keypedia.com/records/fda_inspections/recipharm-karlskoga-ab/9bcbb164-c137-4483-a263-de9d7b827182
Source feed: FDA_Inspections

> FDA Inspection 878699 for Recipharm Karlskoga AB on May 15, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 878699
- Company Name: Recipharm Karlskoga AB
- Inspection Date: 2014-05-15
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1264910 - 2023-04-21](https://www.keypedia.com/records/fda_inspections/recipharm-karlskoga-ab/aa3c0404-0855-4dbe-b3dd-159118f0fd6c)
- [FDA Inspection 1089159 - 2018-03-22](https://www.keypedia.com/records/fda_inspections/recipharm-karlskoga-ab/12459134-28a6-467c-a573-9ce777321cb9)
- [FDA Inspection 776993 - 2012-04-05](https://www.keypedia.com/records/fda_inspections/recipharm-karlskoga-ab/5c51a867-0511-479f-869e-39ef06321b26)

Company: https://www.keypedia.com/companies/recipharm-karlskoga-ab/0f203262-3e69-488e-b3c3-86975ab08957

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c